Rothschild Investment LLC Trims Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Rothschild Investment LLC lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,284 shares of the company’s stock after selling 268 shares during the quarter. Rothschild Investment LLC’s holdings in GE HealthCare Technologies were worth $179,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in GEHC. Cherry Creek Investment Advisors Inc. grew its holdings in shares of GE HealthCare Technologies by 0.3% during the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock worth $2,920,000 after purchasing an additional 114 shares in the last quarter. Independence Bank of Kentucky grew its holdings in shares of GE HealthCare Technologies by 6.0% during the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company’s stock worth $158,000 after purchasing an additional 114 shares in the last quarter. Tandem Capital Management Corp ADV grew its holdings in shares of GE HealthCare Technologies by 0.4% during the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock worth $2,205,000 after purchasing an additional 118 shares in the last quarter. Arcus Capital Partners LLC grew its holdings in shares of GE HealthCare Technologies by 3.0% during the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company’s stock worth $322,000 after purchasing an additional 119 shares in the last quarter. Finally, Custom Index Systems LLC lifted its position in GE HealthCare Technologies by 4.4% in the 4th quarter. Custom Index Systems LLC now owns 2,843 shares of the company’s stock worth $222,000 after buying an additional 120 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $90.81 on Wednesday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The stock has a 50 day moving average price of $85.49 and a two-hundred day moving average price of $86.01. The company has a market capitalization of $41.53 billion, a P/E ratio of 20.97, a PEG ratio of 3.19 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the company. Citigroup boosted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.